Contamination of surface, ground, and drinking water from pharmaceutical production

Environmental Toxicology and Chemistry - Tập 28 Số 12 - Trang 2522-2527 - 2009
Jerker Fick1, Hanna Söderström1, Richard H. Lindberg1, Chau Phan1, Mats Tysklind1, D. G. Joakim Larsson2
1Department of Chemistry, Umeå University, Linneausväg 6, SE-90187 Umeå, Sweden
2Department of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, SE-405 30 Gothenburg, Sweden

Tóm tắt

Abstract

Low levels of pharmaceuticals are detected in surface, ground, and drinking water worldwide. Usage and incorrect disposal have been considered the major environmental sources of these microcontaminants. Recent publications, however, suggest that wastewater from drug production can potentially be a source of much higher concentrations in certain locations. The present study investigated the environmental fate of active pharmaceutical ingredients in a major production area for the global bulk drug market. Water samples were taken from a common effluent treatment plant near Hyderabad, India, which receives process water from approximately 90 bulk drug manufacturers. Surface water was analyzed from the recipient stream and from two lakes that are not contaminated by the treatment plant. Water samples were also taken from wells in six nearby villages. The samples were analyzed for the presence of 12 pharmaceuticals with liquid chromatography‐mass spectrometry. All wells were determined to be contaminated with drugs. Ciprofloxacin, enoxacin, cetirizine, terbinafine, and citalopram were detected at more than 1 μg/L in several wells. Very high concentrations of ciprofloxacin (14 mg/L) and cetirizine (2.1 mg/L) were found in the effluent of the treatment plant, together with high concentrations of seven additional pharmaceuticals. Very high concentrations of ciprofloxacin (up to 6.5 mg/L), cetirizine (up to 1.2 mg/L), norfloxacin (up to 0.52 mg/L), and enoxacin (up to 0.16 mg/L) were also detected in the two lakes, which clearly shows that the investigated area has additional environmental sources of insufficiently treated industrial waste. Thus, insufficient wastewater management in one of the world's largest centers for bulk drug production leads to unprecedented drug contamination of surface, ground, and drinking water. This raises serious concerns regarding the development of antibiotic resistance, and it creates a major challenge for producers and regulatory agencies to improve the situation.

Từ khóa


Tài liệu tham khảo

10.1016/S0378-4274(02)00041-3

10.1021/es011055j

10.1021/es048143z

10.1016/j.aquatox.2005.09.009

10.1177/009286150704100202

10.1007/s00216-006-1035-8

Bisarya SC, 1993, Determination of salicylic‐acid and phenol (ppm level) in effluent from aspirin plant, Research and Industry, 38, 170

10.1007/s10661-005-9139-8

10.1016/j.jhazmat.2007.07.008

10.1897/07-080.1

Larsson DGJ, 2008, Pharmaceuticals in the Environment. Sources, Fate, Effects and Risks

10.1016/j.yrtph.2009.01.008

10.1023/A:1010307026457

10.1016/j.chroma.2008.10.090

BoralkarDB AlvaresC DevottaS SharmaPN ThyagarajanG.2004.Report of visit to Hyderabad (A.P.) October 19–20. Supreme Court Monitoring Committee on Hazardous Wastes. Supreme Court of India New Delhi.

Schulz M, 2003, Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics, Pharmazie, 58, 447

10.1126/science.1159483

10.1126/science.1155157

10.1128/AEM.64.9.3499-3502.1998

10.1111/j.1462-2920.2009.01878.x

10.3201/eid1402.070677

10.1038/nature02241

10.1016/S0378-4274(03)00071-7

10.1016/j.scitotenv.2004.03.015

10.1016/j.jhydrol.2007.09.054

10.1007/s10393-007-0105-5

10.1016/S0166-445X(99)00069-7

10.1897/04-210R.1

10.1897/08-524.1

10.1016/j.chemosphere.2005.01.032

10.1016/j.watres.2008.10.039

10.1897/08-059.1

10.1016/S0045-6535(02)00387-9

10.1016/S0022-1694(02)00165-8

10.1002/hyp.6649

10.1007/BF02986257

10.1007/s00027-003-0672-7

10.1007/s00216-006-0843-1